Study on prevention of hypercapnia by Nasal High Flow in patients undergoing endoscopic retrograde cholangiopancreatography during intravenous anesthesia
- Conditions
- Biliary disease
- Registration Number
- JPRN-jRCTs072190021
- Lead Sponsor
- Ayuse Takao
- Brief Summary
CONCLUSIONS: Respiratory support by NHF with room air did not reduce marked hypercapnia during ERCP under sedation relative to LFO. There was no significant difference in the occurrence of hypoxemia between the groups that may indicate an improvement of gas exchanges by NHF.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
1) Age: Adult patients whose age is between 20 and 85 years old at the time of obtaining consent
2) Gender: Any question
3) Hospitalization / outpatient: hospitalization only
4) Patients who have received sufficient explanation for participation in this study, and who have received sufficient written consent from the patient himself / herself with sufficient understanding.
1) Continuous administration of oxygen by nasal cannula (home oxygen therapy)
2) Patients who cannot breathe nose
3) Patients who cannot reduce or discontinue antithrombotic drugs on the day before the endoscope
4) Patients with a history of pneumothorax
5) Other patients who are determined to be inappropriate as research subjects by the principal investigator
6) Patients who are positive for the new coronavirus (SARS-CoV-2) PCR test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method